Delirium, described as an acute neuropsychiatric syndrome, occurs commonly in critically ill patients and leads to many negative outcomes including increased mortality and long-term cognitive deficits. Despite the lack of clinical data supporting the use of antipsychotics for the management of intensive care unit (ICU) delirium, pharmacological interventions are often needed to control acutely agitated patients. Given that the most current guidelines do not advocate the use of haloperidol for either the prevention or treatment of ICU delirium due to a lack of evidence, second-generation antipsychotics (SGAs) have been commonly used as alternatives to haloperidol for ICU patients with delirium. Nonetheless, the evidence supporting the use of SGAs to treat ICU delirium remains limited. This review is designed to assess the available clinical evidence and highlights the different neuropharmacological and safety properties of SGAs in order to guide the rational use of SGAs for the treatment of ICU delirium.
ElyEWGautamSMargolinR. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27(12):1892–1900.
3.
JacksonJCGordonSMHartRP. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev. 2004;14(2):87–98.
4.
ElyEWShintaniATrumanB. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753–1762.
5.
JacobiJFraserGLCoursinDB. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119–41.
6.
BarrJFraserGPuntilloK. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
DevlinJWBhatSRobertsRJ. Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight states. Ann Pharmacother. 2011;45(10):1217–1229.
9.
DevlinJWRobertsRJFongJJ. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010;38(2):419–427.
10.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
11.
MaldonadoJ. Delirium in the acute care setting: characteristics, diagnosis and treatment. Crit Care Clin. 2008;24(4):657–722.
12.
OuimetSKavanaghBGottfriedS. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33(1):66–73.
13.
PisaniMARedlichCMcNicollL. Underrecognition of preexisting cognitive impairment by physicians in older ICU patients. Chest. 2003;124(6):2267–2274.
14.
MaldonadoJR. Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin. 2008;24(4):789–856.
15.
TuneLE. Serum anticholinergic activity levels and delirium in the elderly. Semin Clin Neuropsychiatry. 2000;5(2):149–153.
16.
GibsonGEPetersonC. Aging decreases oxidative metabolism and the release and synthesis of acetylcholine. J Neurochem. 1981;37(4):978–984.
17.
GibsonGEPetersonC. Decreases in the release of acetylcholine in vitro with low oxygen. Biochem Pharmacol.1982;31(1):111–115.
18.
TakayamaHMizukawaKOtaZOgawaN. Regional responses of rat brain muscarinic cholinergic receptors to immobilization stress. Brain Res. 1987;436(2):291–295.
19.
TrzepaczPT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry. 2000;5(2):132–148.
20.
MillerR. Major psychosis and dopamine: controversial features and some suggestions. Psychol Med. 1984;14(4):779–789.
21.
SieverLJKahnRSLawlorBA. Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacol Rev. 1991;43(4):509–525.
22.
TashiroMYanaiK. Molecular imaging of histamine receptors in the human brain [in Japanese]. Brain Nerve. 2007;59(3):221–231.
23.
PrellGDGreenJPKaufmannCA. Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995;14(2):93–104.
24.
McEvoyLKSmithMEFordyceM. Characterizing impaired functional alertness from diphenhydramine in the elderly with performance and neurophysiologic measures. Sleep. 2006;29(7):957–966.
25.
KimKYMcCartneyJRKayeW. The effect of cimetidine and ranitidine on cognitive function in postoperative cardiac surgical patients. Int J Psychiatr Med. 1996;26(3):295–307.
26.
WeinhouseGLSchwabRJWatsonPL. Bench-to-bedside review: delirium in ICU patients—importance of sleep deprivation. Crit Care. 2009;13(6):234.
27.
PatelJBaldwinJBuntingP. The effect of a multicomponent multidisciplinary bundle of interventions on sleep and delirium in medical and surgical intensive care patients. Anaesthesia. 2014;69(6):540–549.
28.
SchweickertWDPohlmanMCPohlmanAS. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874–18812.
29.
ElyEInouyeSBernardG. Delirium in mechanically ventilated patients. Validity and reliability of the confusion assessment method for the intensive care unit. JAMA. 2001;286(21):2703–2710.
30.
Van EijkMMvan MarumRJKlijnIA. Comparison of delirium assessment tools in a mixed intensive care unit. Crit Care Med. 2009;37(6):1881–1885.
31.
SpragueDALoewenPSRaymondCB. Selection of atypical antipsychotics for the management of schizophrenia. Ann Pharmacother. 2004;38(2):313–319.
32.
BrownCSMarkowitzJSMooreTR. Atypical antipsychotics. Part II: adverse effects, drug interactions, and costs. Ann Pharmacother. 1999;33(2):210–217.
ReaRBattistoneSFongJ. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy. 2007;27(4):588–594.
43.
SkrobikYKBergeronNDumontM. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med. 2004;30(3):444–449.
44.
RiedelMMullerNStrassnigM. Quetiapine in the treatment of schizophrenia and related disorders. Neuropsychiatr Dis Treat. 2007;3(2):219–235.
45.
LiebermanJAStroupTSMcAvoyJP. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–1223.
46.
GardnerDMMurphyALKutcherS. Evidence review and clinical guidance for the use of ziprasidone in Canada. Ann Gen Psychiatry. 2013;12(1):1.
47.
GirardTDPandharipandePPCarsonSS. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med. 2010;38(2):428–437.
48.
BondyBSpellmannI. Pharmacogenetics of antipsychotics: useful for the clinician?Curr Opin Psychiatry. 2007;20(2):126–130.
49.
KroppSLichtinghagenRWintersteinK. Cytochrome P-450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatry. Clin Lab. 2006;52(5-6):237–240.
50.
LetsasKPSiderisAKounasS. Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine. Int J Cardiol. 2006;109(2):273–274.
51.
ReymoldsGPArranzBTemplemanL. Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. Am J Psychiatry. 2006;163(10):1826–1829.
52.
RayWAChungCPMurrayKT. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Eng J Med. 2009;360(3):225–235.
53.
BanhHL. Management of delirium in adult critically ill patients: an overview. J Pharm Pharmaceut Sci. 2012;15(4):499–509.
54.
GilchristNAAsohIGreenbergB. Analytic reviews: a typical antipsychotics for the treatment of ICU delirium. J Intensive Care Med. 2012;27(6);354–361.
55.
LacroJPFarhadianSEndow-EyerRA. Schizophrenia. In: AlldredgeBKCorelliRLErnstME., eds. Applied Therapeutics: The Clinical Use of Drugs. 10th ed. Philadelphia, PA: Lippincott Williams, & Wilkins; 2013:1921–1948.
